SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GLGC Gene Logic

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: keokalani'nui who wrote (194)4/23/2005 1:10:32 PM
From: Steve Lokness  Read Replies (2) of 360
 
Isn't Perlegen and DCGN doing almost the same thing - but while Perlegen is finding the information in animals, DCGN is looking at the human genome?

<<I don't know how a drug could make it through
big pharma and miss an indication.>>
Is it the indication they are looking at - or a specif subset of the population? If you could salvage a drug by determining what it was that was toxic (GLGC)to some - but allowed the drug to work for others, that could be very beneficial. Since GLGC is partnering these candidates, might they be able to make money no matter what the outcome?

Steve
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext